Keeping an Eye on Krystal Biotech Inc (KRYS) After Insider Trading Activity

Krystal Biotech Inc’s recent filing unveils that its President, R&D Krishnan Suma unloaded Company’s shares for reported $1.04 million on Jul 10 ’25. In the deal valued at $150.27 per share,6,927 shares were sold. As a result of this transaction, Krishnan Suma now holds 1,525,929 shares worth roughly $225.43 million.

Then, Krishnan Suma sold 6,800 shares, generating $1,021,880 in total proceeds. Upon selling the shares at $150.28, the President, R&D now owns 1,456,711 shares.

Before that, Krishnan Suma sold 200 shares. Krystal Biotech Inc shares valued at $30,028 were divested by the President, R&D at a price of $150.14 per share. As a result of the transaction, Krishnan Suma now holds 1,463,511 shares, worth roughly $216.2 million.

Jefferies initiated its Krystal Biotech Inc [KRYS] rating to a Buy in a research note published on March 05, 2025; the price target was $245. A number of analysts have revised their coverage, including Citigroup’s analysts, who decreased its forecast for the stock in early August from “a Buy” to “a Neutral”. Goldman began covering KRYS with “Buy” recommendation on November 20, 2023. Cantor Fitzgerald started covering the stock on October 24, 2023. It rated KRYS as “an Overweight”.

Price Performance Review of KRYS

On Tuesday, Krystal Biotech Inc [NASDAQ:KRYS] saw its stock fall -1.78% to $147.73. Over the last five days, the stock has gained 3.07%. Krystal Biotech Inc shares have fallen nearly -25.54% since the year began. Nevertheless, the stocks have fallen -5.70% over the past one year. While a 52-week high of $219.34 was reached on 03/25/25, a 52-week low of $122.80 was recorded on 05/23/25.

Levels Of Support And Resistance For KRYS Stock

The 24-hour chart illustrates a support level at 145.90, which if violated will result in even more drops to 144.06. On the upside, there is a resistance level at 150.81. A further resistance level may holdings at 153.88.

How much short interest is there in Krystal Biotech Inc?

A steep rise in short interest was recorded in Krystal Biotech Inc stocks on 2025-06-13, growing by 0.43 million shares to a total of 3.03 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 2.6 million shares. There was a rise of 14.25%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on October 12, 2023 when Citigroup began covering the stock and recommended ‘”a Buy”‘ rating along with a $160 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.